SCHEMBL1887592

SCHEMBL1887592

CCCCCO[P](=O)Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL459859 0.81
SCHEMBL5145331 0.79 CA1 (0.41)
SCHEMBL887259 0.79 THRB (0.37)
SCHEMBL5625359 0.79 TSHR (0.44)
SCHEMBL11663426 0.79 TSHR (0.44)
SCHEMBL27283702 0.79 TSHR (0.44)
SCHEMBL11416111 0.79 TSHR (0.44)
SCHEMBL9329861 0.77 THRB (0.42)
SCHEMBL9329817 0.77 THRB (0.42)
SCHEMBL9225312 0.77 CA1 (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7939510-B2 Di(uridine 5′-)tetraphosphate and salts thereof INSPIRE PHARMACEUTICALS, INC. (US) 2011-05-10 US disclosed
US-20090326050-A1 DI(URIDINE 5'-)TETRAPHOSPHATE AND SALTS THEREOF MERCK SHARP & DOHME CORP. 2009-12-31 US disclosed
US-7528119-B2 Di(uridine 5′-)tetraphosphate and salts thereof INSPIRE PHARMACEUTICALS, INC. (US) 2009-05-05 US disclosed
US-20060258615-A1 Di(uridine 5'-)tetraphosphate and salts thereof MERCK SHARP & DOHME CORP. 2006-11-16 US disclosed
US-7132410-B2 Di(uridine 5′-)tetraphosphate and salts thereof INSPIRE PHARMACEUTICALS, INC. (US) 2006-11-07 US disclosed
US-7091334-B2 Dissolving uridine nucleotide compound in a polar, aprotic organic solvent and a hydrophobic amine; activating, reacting with second uridine compound, purifying by chromatography INSPIRE PHARMACEUTICALS, INC. (US) 2006-08-15 US disclosed
US-20050148540-A1 Di(uridine 5'-)tetraphosphate and salts thereof MERCK SHARP & DOHME CORP. 2005-07-07 US disclosed
US-6872710-B2 Di(uridine 5′)-tetraphosphate and salts thereof INSPIRE PHARMACEUTICALS, INC. (US) 2005-03-29 US disclosed
US-20040267005-A1 Method for large-scale production of di(uridine 5')-tetraphosphate and salts thereof MERCK SHARP & DOHME CORP. 2004-12-30 US disclosed
US-6765090-B2 DRUGS; STABILITY, SOLUBILITY, NONTOXIC, EASY TO HANDLE INSPIRE PHARMACEUTICALS, INC. 2004-07-20 US disclosed
US-6713458-B1 DRY EYE; RETINAL DETACHMENT INSPIRE PHARMACEUTICALS, INC. 2004-03-30 US disclosed
EP-1012154-B1 SALTS OF DI(URIDINE 5'-TETRAPHOSPHATE), METHOD FOR PREPARATION AND USES THEREOF INSPIRE PHARMACEUTICALS INC (US) 2004-03-17 EP disclosed
US-20040014713-A1 Di(uridine 5')-tetraphosphate and salts thereof MERCK SHARP & DOHME CORP. 2004-01-22 US disclosed
US-6548658-B2 Tetrasodium, ammonium, lithium and potassium salts of P1, P4-di(uridine 5')-tetraphosphate; stable, soluble, nontoxic, of high purity and easy to handle during manufacture INSPIRE PHARMACEUTICALS, INC. 2003-04-15 US disclosed
US-20020086851-A1 Method for large-scale production of di(uridine 5')-tetraphosphate and salts thereof MERCK SHARP & DOHME CORP. 2002-07-04 US disclosed
US-6319908-B1 FOR THERAPY CYSTIC FIBROSIS, CHRONIC BRONCHITIS, ASTHMA, BRONCHIECTASIS, POST-OPERATIVE MUCOUS RETENTION, PNEUMONIA, PRIMARY CILIARY DYSKINESIA INSPIRE PHARMACEUTICALS, INC. 2001-11-20 US disclosed
US-20010011079-A1 Method for large-scale production of di(uridine 5')-tetraphosphate and salts thereof MERCK SHARP & DOHME CORP. 2001-08-02 US disclosed
EP-1012154-A2 SALTS OF DI(URIDINE 5'-TETRAPHOSPHATE), METHOD FOR PREPARATION AND USES THEREOF Inspire Pharmaceuticals, Inc. (US) 2000-06-28 EP disclosed
WO-1999005155-A2 SALTS OF DI(URIDINE 5'-TETRAPHOSPHATE), METHOD FOR PREPARATION AND USES THEREOF INSPIRE PHARMACEUTICALS, INC. (US) 1999-02-04 WO disclosed